Last paragraph for laughs

Discussion in 'Synthetic Drugs' started by TokeTrip, Oct 7, 2007.

  1. TokeTrip

    TokeTrip Senior Member

    Messages:
    1,102
    Likes Received:
    2
    From the August 2007 Microgram:
    - INTELLIGENCE ALERT -
    "BROMO DRAGONFLY" (BROMO-BENZODIFURANYL-ISOPROPYLAMINE)
    IN ASHLAND, OREGON

    [size=-1]The Oregon State Police Central Point Laboratory recently received a small amber dropper bottle containing approximately 3 milliliters of a clear colorless liquid, submitted as “Bromo” and suspected to be a solution of 2,5-dimethoxy-4-bromoamphetamine (DOB) (no photos). The exhibit was seized at a residence in Ashland, Oregon by the Ashland Police, pursuant to a consent search. A small amount of marijuana and a set of scales were also seized. The solution was determined to be aqueous, with a pH of approximately 5. Analysis by GC/MS, UV/Vis, and FTIR/ATR, however, indicated not DOB but rather bromo-benzodifuranyl-isopropylamine (also known as “Bromo Dragonfly”; see Figure 1). The identification was not confirmed due to lack of a standard; however, the mass spectrum matched the literature. The solution was not quantitated but was a moderate loading based on the TIC. This is the first submission of this type to the Oregon State Police laboratory system.[/size]
    [​IMG]
    [size=-1]Figure 1 - “Bromo Dragonfly”
    (1-(8-Bromobenzo[1,2-b:4,5-b']difuran-4-yl)-2-aminopropane
    C13H12BrNO2; mw = 294.14
    [/size]

    [size=-1][Editor’s Notes: Currently, there is only sparse information available on this compound. It is allegedly a long-lasting, DOB-like hallucinogen with a dosage unit of approximately 0.5 milligrams. In contrast to most amphetamine-like compounds, the R configuration is reportedly the more active enantiomer. This is the first report of this compound in Microgram[/size]

    I enjoy the last paragraph
     
  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice